Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05096260 · ClinicalTrials.gov registry record · NA
Getting to Yes, Michigan! (G2YMI)
A NA study of COVID-19 Pandemic and COVID-19 Vaccines, sponsored by University of Michigan.
- Active
- Registry status
- NA
- Development phase
- 700
- Enrollment target
- 1
- Study location
NCT05096260 is a NA study of COVID-19 Pandemic and COVID-19 Vaccines that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 700 participants, below the 935-participant average among 3 other COVID-19 Pandemic trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05096260, a NA study of COVID-19 Pandemic and COVID-19 Vaccines, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 700 participants
- Enrollment target
- 1
- Study location
Study Summary
This study entitled Community-Centered Interventions for Improved Vaccine Uptake for COVID-19 (CIVIC): Getting to Yes, Michigan!, is designed to increase vaccine uptake among populations that experience COVID-19 related disparities. The investigators will focus on the four counties within Michigan where a disproportionate burden of COVID-19 is within African Americans and Latinx communities, i.e., Wayne, Genesee, Kent and Washtenaw Counties. Using a community-based participatory research (CBPR) approach, CIVIC will leverage: its long term relationships with the communities involved, an established CBPR Steering Committee developed and the knowledge gained as a Community Engagement Alliance (CEAL) grant recipient, the resources and networks of the University of Michigan CTSA (MICHR), and the expertise of our academic partners to identify and understand factors that contribute to COVID-19 vaccine hesitancy in African Americans and Latinx communities in Michigan. The investigators will develop and test interventions based on community-centered approaches to achieve a primary goal of increased vaccine uptake. The investigators will achieve this goal with the following aims: 1. Increase understanding of the barriers and drivers of vaccine uptake and hesitancy; 2. Increase vaccine uptake and decrease vaccine hesitancy through the implementation and evaluation of a multi-component intervention; and maintain, enhance, and evaluate the effectiveness of the CIVIC partnership to equitably engage all partners.
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing based SMS/MMS and web content
Study Locations (1)
Michigan
- Michigan Medicine - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2022-07-05 |
| Est. Completion | 2026-03-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05096260
The ClinicalTrials.gov registry entry for NCT05096260 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 3 other COVID-19 Pandemic trials with a reported enrollment target (25% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with COVID-19 Pandemic appearing as the primary indexed condition, and to 1 intervention - of which Motivational Interviewing based SMS/MMS and web content is the first listed.
NCT05096260 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05096260 about?
NCT05096260 is a clinical study titled "Getting to Yes, Michigan! (G2YMI)". This study entitled Community-Centered Interventions for Improved Vaccine Uptake for COVID-19 (CIVIC): Getting to Yes, Michigan!, is designed to increase vaccine uptake among populations that experience COVID-19 related disparities. The investigators will focus on the four counties within Michigan w...
What is the current status of trial NCT05096260?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 700 participants. The study started on 2022-07-05. Estimated completion is 2026-03-11.
What conditions does trial NCT05096260 study?
This clinical trial studies the following conditions: COVID-19 Pandemic, COVID-19 Vaccines.
What interventions are being tested in trial NCT05096260?
The interventions under investigation include: Motivational Interviewing based SMS/MMS and web content (BEHAVIORAL).
Who is sponsoring clinical trial NCT05096260?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05096260 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19 Pandemic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.